COMMERCIAL BIAS at STANFORD and CORCEPT
Stanford University has replaced Dr.
Alan Schatzberg as Principal Investigator on his NIH grant that studies psychotic depression. This step followed persistent questions from Senator Grassley about conflicts of interest and financial disclosure.
Dr. Schatzberg’s drug mifepristone has been in NIH-supported clinical trials at Stanford and in FDA-monitored trials sponsored by Corcept, the company Dr.
Schatzberg founded.
The University emphasized “We want to put to rest confusion about the integrity of...
Post new comment